| Dr Sarath Gangavarapu, MD | |
|
1001 N James Campbell Blvd, Columbia, TN 38401 | |
| (931) 777-6180 | |
| Not Available |
| Full Name | Dr Sarath Gangavarapu |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 45 Years |
| Location | 1001 N James Campbell Blvd, Columbia, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194755124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD0000016350 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centennial Psychiatric Associates, Llc | 3971654278 | 10 |
News Archive
Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.
Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that Dr. Francisco Leon, CEO and Chief Medical Officer, will provide an oral presentation on an abstract related to the company's lead product candidate, AMG 714, at the 16th International Coeliac Disease Symposium, June 24, 2015, in Prague, Czech Republic.
Invasive treatment including stenting may have better outcomes than conventional treatments for heart attack patients who arrive at the hospital more than 12 hours after symptoms began, according to a study in the June 15 issue of JAMA.
› Verified 7 days ago
| Entity Name | Centennial Psychiatric Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467687822 PECOS PAC ID: 3971654278 Enrollment ID: O20090626000285 |
News Archive
Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.
Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that Dr. Francisco Leon, CEO and Chief Medical Officer, will provide an oral presentation on an abstract related to the company's lead product candidate, AMG 714, at the 16th International Coeliac Disease Symposium, June 24, 2015, in Prague, Czech Republic.
Invasive treatment including stenting may have better outcomes than conventional treatments for heart attack patients who arrive at the hospital more than 12 hours after symptoms began, according to a study in the June 15 issue of JAMA.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarath Gangavarapu, MD 7533 Tee Way Cir, Chattanooga, TN 37416-1091 Ph: (423) 505-4673 | Dr Sarath Gangavarapu, MD 1001 N James Campbell Blvd, Columbia, TN 38401 Ph: (931) 777-6180 |
News Archive
Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.
Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that Dr. Francisco Leon, CEO and Chief Medical Officer, will provide an oral presentation on an abstract related to the company's lead product candidate, AMG 714, at the 16th International Coeliac Disease Symposium, June 24, 2015, in Prague, Czech Republic.
Invasive treatment including stenting may have better outcomes than conventional treatments for heart attack patients who arrive at the hospital more than 12 hours after symptoms began, according to a study in the June 15 issue of JAMA.
› Verified 7 days ago
Ralph I Barr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 School St, Columbia, TN 38401 Phone: 931-490-1400 Fax: 931-490-1462 | |
Anthony Chuka Ekwo, M.D. MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Ruth Clinic, 1300 Hatcher Lane, Columbia, TN 38401 Phone: 931-548-3177 | |
Louise Y Ledbetter, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 927 N. James Campbell Blvd., Suite 105, Columbia, TN 38401 Phone: 931-388-5114 Fax: 931-388-5631 | |
Dr. Elizabeth Ann Null, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1222 Trotwood Ave, Suite 101, Columbia, TN 38401 Phone: 931-490-7348 Fax: 931-490-7349 | |
Glenn R Yank, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 854 W James Campbell Blvd, Suite 201, Columbia, TN 38401 Phone: 931-490-0999 Fax: 931-490-0555 | |
Dr. Jeffry Carle Ruff Jr., D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1222 Trotwood Ave, Ste. 101, Columbia, TN 38401 Phone: 931-490-7348 Fax: 931-490-7349 |